Ossiam’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-70
| Closed | -$23K | – | 621 |
|
|
2024
Q4 | $23K | Sell |
70
-472
| -87% | -$155K | ﹤0.01% | 598 |
|
|
2024
Q3 | $181K | Sell |
542
-242
| -31% | -$81K | ﹤0.01% | 546 |
|
|
2024
Q2 | $214K | Buy |
784
+40
| +5% | +$10.9K | ﹤0.01% | 529 |
|
|
2024
Q1 | $257K | Buy |
744
+264
| +55% | +$91.3K | ﹤0.01% | 556 |
|
|
2023
Q4 | $155K | Buy |
480
+4
| +0.8% | +$1.29K | ﹤0.01% | 604 |
|
|
2023
Q3 | $171K | Sell |
476
-131
| -22% | -$47K | ﹤0.01% | 611 |
|
|
2023
Q2 | $230K | Buy |
607
+307
| +102% | +$116K | ﹤0.01% | 586 |
|
|
2023
Q1 | $144K | Buy |
300
+16
| +6% | +$7.66K | ﹤0.01% | 533 |
|
|
2022
Q4 | $119K | Hold |
284
| – | – | ﹤0.01% | 545 |
|
|
2022
Q3 | $118K | Buy |
284
+256
| +914% | +$106K | ﹤0.01% | 533 |
|
|
2022
Q2 | $14K | Sell |
28
-3,864
| -99% | -$1.93M | ﹤0.01% | 406 |
|
|
2022
Q1 | $2.19M | Buy |
3,892
+3,823
| +5,541% | +$2.15M | 0.06% | 169 |
|
|
2021
Q4 | $52K | Buy |
69
+48
| +229% | +$36.2K | ﹤0.01% | 389 |
|
|
2021
Q3 | $16K | Hold |
21
| – | – | ﹤0.01% | 421 |
|
|
2021
Q2 | $16K | Buy |
+21
| New | +$16K | ﹤0.01% | 426 |
|
|
2021
Q1 | – | Sell |
-1,147
| Closed | -$669K | – | 415 |
|
|
2020
Q4 | $669K | Sell |
1,147
-420
| -27% | -$245K | 0.02% | 242 |
|
|
2020
Q3 | $808K | Sell |
1,567
-1,268
| -45% | -$654K | 0.03% | 208 |
|
|
2020
Q2 | $1.28M | Buy |
+2,835
| New | +$1.28M | 0.08% | 149 |
|